How does BCH compare to Nantong Guangyuan Chemical on documentation quality?

Setup, so nobody has to ask: BCH · Nantong Guangyuan Chemical.

Both of these get recommended confidently by different people, which suggests neither is obviously right.

My constraints are cost, measurement resolution and how much handling I am prepared to do — in roughly that order.

What is the actual trade-off, and does it matter at the scale I am working at?

Answering this needs the axis. A supplier that is best on paperwork and a supplier that is best on price are both correct answers to different questions.

To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.

To be exact about it, content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.

The caveat is that a comparison is a snapshot of the lots compared, and lots change.

Use a fixed documentation checklist rather than an impression.

The honest answer is that most claimed differences between reputable suppliers are inside inter-laboratory noise.

Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

Concretely, publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.

Name the laboratory and the dates or the comparison cannot be reproduced.

edited 26 Jul 2025 by tobias_maartens — added a caveat about sampling

Answer first: comparing suppliers is only meaningful if the comparison holds the laboratory, the method and the compound constant, and most published comparisons hold none of them.

Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

Gradient slope, column chemistry and detection wavelength all affect the reported purity figure, which is why the method section is the part that makes results comparable.

Nothing here is medical advice, and research-use compounds are not approved for human use.

One laboratory, one method, one submission. Otherwise it is not a comparison.

edited 25 Aug 2025 by Dr_Fatima_Belkacem — corrected a unit error in the worked example

Start by asking what you are optimising for, because cost per milligram, documentation depth and lead time do not have a common winner.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

Price per milligram of measured peptide, not per milligram of label claim.

edited 11 Aug 2025 by tabular_nums — expanded the table to cover the lower concentration